Alcohol Withdrawal Clinical Trial
— OSTEOOLOfficial title:
Contribution of Osteopathic Treatment to Alcohol Withdrawal Syndrome in Hospitalized Adult Patients
The alcohol withdrawal syndrome has a hierarchical symptomatology depending on the severity (minor, moderate or severe). These signs express a state of psychic, behavioral and physical deprivation. The management of withdrawal syndrome involves the establishment of pharmacological and psychosocial interventions. Osteopathy is an exclusively manual practice whose purpose is to overcome the dysfunction of mobility of tissues of the human body. It can be used as a complementary treatment when a specific support is put in place. The purpose of this study is to examine the effectiveness of osteopathy in reducing alcohol withdrawal symptoms in adult patients.
Status | Recruiting |
Enrollment | 50 |
Est. completion date | February 13, 2024 |
Est. primary completion date | December 13, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria : - Age> 18 years - Patient hospitalized for a programmed alcohol withdrawal - Patient not abstinent with alcohol before hospitalization - Signed informed consent Exclusion Criteria : - Minor patient - Patient with an addiction other than alcohol (except tobacco and benzodiazepines) - Previous participation in the OSTEOOL study |
Country | Name | City | State |
---|---|---|---|
France | Chi Creteil | Creteil |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Intercommunal Creteil | Ecole Supérieur d'Ostéopathie |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cushman score (0 to 27) | comparison between the two groupe of the cushamn socre between 11:30 am and 00:00 pm. questionary for alcohol dependency | Day one | |
Secondary | CIWA Ar (Clinicial Institute Withdrawal Assessment - Alcohol Revised) test (0 to 67) | comparison between the two groups with this questionary for alcohol withdrawal | day 0 | |
Secondary | CIWA Ar test (0 to 67) | comparison between the two groupe with this questionary for alcohol withdrawal | day 1 | |
Secondary | CIWA Ar test (0 to 67) | compariason between the two groups with this questionary for alcohol withdrawal | day 2 | |
Secondary | CIWA Ar test (0 to 67) | comparison between the two groups with this questionary for alcohol withdrawal | day 3 | |
Secondary | CIWA Ar test (0 to 67) | comparison between the two groups with this questionary for alcohol withdrawal | day 4 | |
Secondary | cardiac frequency (beat per minute) | mesurement of cardiac frequency and compaaison between the two groups | day 1 | |
Secondary | cardiac frequency (beat per minute) | mesurement of cardiac frequency and comparison between the two groups | day 3 | |
Secondary | cardiac frequency (beat per minute) | measurement of cardiac frequency and comparison between the two groups | day 4 | |
Secondary | quality sleep scale (0 to 5) | comparison between the two groups with sleep score | day 0 | |
Secondary | quality sleep scale (0 to 5) | comparison between the two groups with sleep score | day 1 | |
Secondary | quality sleep scale (0 to 5) | comparison between the two groups with sleep score | day 2 | |
Secondary | quality sleep scale (0 to 5) | comparison between the two groups with sleep score | day 3 | |
Secondary | quality sleep scale (0 to 5) | comparison between the two groups with sleep score | day 4 | |
Secondary | quantity of benzodiazepine mg per 24 hours | comparison between the two groups of benzodiazepin use | day 2 | |
Secondary | quantity of benzodiazepine (mg per 24 hours) | comparison between the two groups of benzodiazepin use | day 3 | |
Secondary | quantity of benzodiazepine (mg per 24 hours) | comparison betwenn the two groups of benzodiazepin use | day 4 | |
Secondary | Cushmamn score (0 to 27) | comparison between the two groups of the Cushamn score between 11:30 am and 00:00 pm | day 3 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04858490 -
Remote Treatment of Alcohol Withdrawal
|
N/A | |
Not yet recruiting |
NCT04997330 -
Evaluation of Bilateral HF-rTMS on Abstinence in Alcohol Use Disorder Patients With Executive Dysfunction
|
N/A | |
Recruiting |
NCT04876443 -
Impact of COVID-19 Outbreak on the Alcohol Consumption in Patients With Alcohol-related Liver Disease (ICoLD)
|
||
Completed |
NCT05131334 -
Auricular Vagal Stimulation in Alcohol Craving
|
N/A | |
Completed |
NCT02349477 -
Gabapentin for Alcohol Relapse Prevention
|
Phase 2 | |
Terminated |
NCT01937364 -
Preventing Alcohol Withdrawal With Oral Baclofen
|
Phase 2 | |
Completed |
NCT05393544 -
Digitally Assisted Recovery Coach
|
N/A | |
Completed |
NCT00523185 -
A Comparison of Lorazepam and Diazepam in the Treatment of Alcohol Withdrawal
|
N/A | |
Completed |
NCT01573052 -
Gabapentin vs Chlordiazepoxide for Ambulatory Alcohol Withdrawal
|
Phase 4 | |
Enrolling by invitation |
NCT06173973 -
Effects of Ketone Supplementation on Acute Alcohol Withdrawal
|
Phase 2/Phase 3 | |
Active, not recruiting |
NCT03737864 -
NCARE, Transition to Recovery
|
N/A | |
Recruiting |
NCT03878225 -
Does a Ketogenic Dietary Supplement Reduce Alcohol Withdrawal Symptoms in Humans?
|
N/A | |
Terminated |
NCT03586089 -
Phenobarbital for Severe Acute Alcohol Withdrawal Syndrome
|
N/A | |
Recruiting |
NCT04156464 -
Phenobarbital vs Ativan for Alcohol Withdrawal in the Intensive Care Unit
|
Phase 4 | |
Completed |
NCT02202148 -
Liver Stiffness Measurement in Alcohol-dependent Subjects in Relation to Abstinence After Withdrawal
|
N/A | |
Completed |
NCT02251912 -
Oxytocin Treatment of Alcohol Dependence
|
Phase 2 | |
Completed |
NCT01212185 -
Oxytocin Treatment of Alcohol Withdrawal
|
Phase 1 | |
Recruiting |
NCT04793685 -
Prazosin for Alcohol Use Disorder With Withdrawal Symptoms
|
Phase 1/Phase 2 | |
Withdrawn |
NCT04159909 -
Using Transcutaneous Auricular Vagus Nerve Stimulation to Treat Acute Alcohol Withdrawal
|
N/A | |
Completed |
NCT05563350 -
Metabolism of Chlordiazepoxide in the Treatment of Alcohol Withdrawal Symptoms
|